Cite
HARVARD Citation
Sugawara, T. et al. (2019). Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models. International journal of cancer. 145 (5), pp. 1382-1394. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sugawara, T. et al. (2019). Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models. International journal of cancer. 145 (5), pp. 1382-1394. [Online].